Handling complex personal injury cases for individuals and families throughout Birmingham
  1. Home
  2.  » 
  3. Firm News
  4.  » ALERT: Walmart, CVS, Walgreens, & Rite Aid Suspend Sales of Heartburn Drug Zantac

ALERT: Walmart, CVS, Walgreens, & Rite Aid Suspend Sales of Heartburn Drug Zantac

On Behalf of | Oct 3, 2019 | Firm News

Montgomery & Ponder, LLC attorneys are investigating claims related to the heartburn drug Zantac. Millions of people may have been unknowingly subjected to dangerous levels of NDMA through ingestion of Zantac.

Reuters reports Walmart suspended the sale of heartburn drugs containing ranitidine because the probable carcinogen NDMA has been detected in some of the drugs. Walmart announced that it would stop selling several brands of the drug just as CVS, Walgreens, and Rite Aid have done. “Walmart Inc on Wednesday became one of the last remaining major U.S. retailers to suspend the sale of over-the-counter heartburn medication containing ranitidine after the U.S. health agency flagged the presence of a probable cancer-causing impurity.”

Heartburn drugs like Zantac contain the key ingredient ranitidine that has been found to have traces of the impurity, N-nitrosodimethylamine (NDMA), leading to Novartis AG halting global distribution of its versions of the popular drug commonly known as Zantac.

Heartburn drugs like Zantac contain the key ingredient ranitidine that has been found to have traces of the impurity, N-nitrosodimethylamine (NDMA), leading to Novartis AG halting global distribution of its versions of the popular drug commonly known as Zantac.

Montgomery Ponder is currently interviewing consumers in the U.S. who regularly used Zantac for at least 60 days and then were diagnosed with stomach, bladder, kidney, pancreatic, or colon cancer. If you or a family member were diagnosed with one of these types of cancer after taking Zantac, please contact Montgomery & Ponder, LLC at (205) 377-5004